Editorial overview: The treatment of liver diseases in 2020-2030

Curr Opin Pharmacol. 2022 Feb:62:1-3. doi: 10.1016/j.coph.2021.10.007. Epub 2021 Nov 30.

Authors

Emmanuel A Tsochatzis¹, Jef Verbeek²

Affiliations

¹ UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom. Electronic address: emmanouil.tsochatzis@nhs.net.
² Department of Gastroenterology & Hepatology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Hepatology, Department of Chronic Diseases and Metabolism, KU Leuven, Belgium. Electronic address: jef.verbeek@uzleuven.be.

PMID: 34861629
DOI: 10.1016/j.coph.2021.10.007

No abstract available

Publication types

Editorial

MeSH terms

Humans
Liver Diseases* / drug therapy
Virus Diseases*